Literature DB >> 22487509

How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?

Tadahiro Uemura1, Lucas E Nikkel, Christopher S Hollenbeak, Varun Ramprasad, Eric Schaefer, Zakiyah Kadry.   

Abstract

Advanced age donors have inferior outcomes of liver transplantation for Hepatitis C (HCV). Aged donors grafts may be transplanted into young or low model for end stage liver disease (MELD) patients in order to offset the effect of donor age. However, it is not well understood how to utilize liver grafts from advanced aged donors for HCV patients. Using the UNOS database, we retrospectively studied 7508 HCV patients who underwent primary liver transplantation. Risk factors for graft failure and graft survival using advanced aged grafts (donor age ≥ 60 years) were analyzed by Cox hazards models, donor risk index (DRI) and organ patient index (OPI). Recipient's age did not affect on graft survival regardless of donor age. Advanced aged grafts had significant inferior survival compared to younger aged grafts regardless of MELD score (P < 0.0001). Risk factors of HCV patients receiving advanced aged grafts included donation after cardiac death (DCD, HR: 1.69) and recent hospitalization (HR: 1.43). Advanced aged grafts showed significant difference in graft survival of HCV patients with stratification of DRI and OPI. In conclusion, there was no offsetting effect by use of advanced aged grafts into younger or low MELD patients. Advanced aged grafts, especially DCD, should be judiciously used for HCV patients with low MELD score.
© 2012 The Authors. Transplant International © 2012 European Society for Organ Transplantation.

Entities:  

Mesh:

Year:  2012        PMID: 22487509     DOI: 10.1111/j.1432-2277.2012.01474.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  7 in total

Review 1.  Transplant for the very sick: No limitations in donor quality?

Authors:  Jennifer C Lai
Journal:  Liver Transpl       Date:  2017-10       Impact factor: 5.799

2.  The corrected donor age for hepatitis C virus-infected liver transplant recipients.

Authors:  Melisa Dirchwolf; Jennifer L Dodge; Jane Gralla; Kiran M Bambha; Trevor Nydam; Kenneth W Hung; Hugo R Rosen; Sandy Feng; Norah A Terrault; Scott W Biggins
Journal:  Liver Transpl       Date:  2015-08       Impact factor: 5.799

3.  Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival following Liver Transplantation for Hepatitis C Virus.

Authors:  Arun Jesudian; Sameer Desale; Jonathan Julia; Elizabeth Landry; Christopher Maxwell; Bhaskar Kallakury; Jacqueline Laurin; Kirti Shetty
Journal:  J Clin Exp Hepatol       Date:  2015-11-12

Review 4.  Expanded criteria donors.

Authors:  Sandy Feng; Jennifer C Lai
Journal:  Clin Liver Dis       Date:  2014-08       Impact factor: 6.126

5.  The Kupffer Cell Number Affects the Outcome of Living Donor Liver Transplantation from Elderly Donors.

Authors:  Masaaki Hidaka; Susumu Eguchi; Mitsuhisa Takatsuki; Akihiko Soyama; Shinichiro Ono; Tomohiko Adachi; Koji Natsuda; Tota Kugiyama; Takanobu Hara; Satomi Okada; Hajime Imamura; Satoshi Miuma; Hisamitsu Miyaaki
Journal:  Transplant Direct       Date:  2016-07-22

6.  The Graz Liver Allocation Strategy-Impact of Extended Criteria Grafts on Outcome Considering Immunological Aspects.

Authors:  Judith Kahn; Gudrun Pregartner; Alexander Avian; Daniela Kniepeiss; Helmut Müller; Peter Schemmer
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561

7.  Ex vivo machine perfusion: current applications and future directions in liver transplantation.

Authors:  Julian Michelotto; Joseph M G V Gassner; Simon Moosburner; Vanessa Muth; Madhukar S Patel; Markus Selzner; Johann Pratschke; Igor M Sauer; Nathanael Raschzok
Journal:  Langenbecks Arch Surg       Date:  2020-11-20       Impact factor: 3.445

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.